Hanh

About Hanh

This author has not yet filled in any details.
So far Hanh has created 112 blog entries.

IVI Demonstrates Commitment to Patient Involvement with Release of “Partnering with Patients” Principles

To demonstrate IVI’s commitment to patient involvement and ensure that the patient perspective is represented in our work, IVI recently developed several documents enumerating the principles and practices that guide this vital partnership. These documents offer detail about the actions IVI takes to involve patients and patient organizations early and often in research, model development and other projects, and establish a basis [...]

2018-05-03T16:33:42+00:00 April 17th, 2018|IVI News|

IVI Releases Public Feedback on Open-Source Value Project Model for Rheumatoid Arthritis

Today, the Innovation and Value Initiative (IVI) released public feedback on the IVI Open-Source Value Project model for rheumatoid arthritis. IVI launched the Open-Source Value Project, a first-of-its-kind effort to better measure value in health care treatments, with the release of an open-source tool focused on measuring value in treatments for RA. The IVI-RA model [...]

2018-05-03T16:32:26+00:00 April 16th, 2018|IVI News, Research|

IVI-RA Value Tool Featured on ISPOR Student Webinar Series

Devin Incerti, Lead Economist on IVI's Open-Source Value Project, will be presenting the IVI-RA Value Tool as one of ISPOR's featured student webinars. See below for the full description and details on the webinar, as well as the registration link. WEBINAR: Developing Flexible, Iterative, and Transparent Decision Models: A Detailed Look at the Rheumatoid Arthritis [...]

2018-05-03T16:31:29+00:00 April 15th, 2018|Event, IVI News|

Patient-Centered Formularies: Steps in the Right Direction, but Challenges Remain

In a post on the IVI-sponsored Health Affairs featured blog series, Drugs and Medical Innovation, Jason Shafrin (IVI Director of Research) and Mark Linthicum (IVI Director of Scientific Communications) explore the role that formularies play in determining value for different stakeholders, and how unique, multi-stakeholder efforts can make formularies more patient-centered. Read the full article [...]

2018-04-16T12:22:51+00:00 April 11th, 2018|Viewpoints|

IVI Responds to ICER’s New Pilot Program

The Institute for Clinical Economic Review (ICER) recently launched a new pilot program that will allow more extensive evaluation of draft economic models used in ICER's reports. In response to ICER's new program, Mark Linthicum, Director of Scientific Communications for the Innovation and Value Initiative (IVI), commented: "The Innovation and Value Initiative (IVI) is working diligently [...]

2018-04-17T15:05:55+00:00 April 3rd, 2018|IVI News, Press|

Using Outcomes-Based Pricing for Medical Devices to Improve Cardiovascular Disease Treatment Value

In a post on the IVI-sponsored Health Affairs featured blog series Drugs and Medical Innovation, Daniel Blumenthal, Samuel Nussbaum (IVI Strategic Advisory Panel Chair), Mark Linthicum (IVI Director of Scientific Communications), and Neil Weissman (IVI Strategic Advisory Panel member) explore how outcomes-based pricing agreements (OBAs) could be utilized for medical devices used to treat cardiovascular [...]

2018-03-30T18:04:16+00:00 March 29th, 2018|Viewpoints|

IVI Names Veteran Health Care Strategist Jennifer Bright as New Acting Executive Director

Bright Brings Decades of Health Care Experience and Established Relationships to IVI Los Angeles, CA - March 5, 2018 - The Innovation and Value Initiative (IVI) - a collaboration dedicated to developing better approaches to measuring value in health care - today announced that Jennifer Bright (pictured left), founder and President of Momentum Health [...]

2018-04-17T15:06:07+00:00 March 5th, 2018|IVI News, Press|

IVI Report Examines Imbalances in Health Care Effectiveness Analyses

A new Innovation and Value Initiative (IVI) report found that cost-effectiveness analyses (CEAs) are disproportionately conducted on pharmaceutical interventions compared to other health care treatments. Learn more about what causes this and the potential policy solutions to achieve better overall balance of CEAs across health care interventions. Read more about the project and results here.

2018-04-17T15:06:48+00:00 February 21st, 2018|IVI News, Research|

To Get Our Money’s Worth in Healthcare, We Need to Collaborate

In a commentary for Modern Healthcare, IVI Director of Scientific Communications, Mark Linthicum, emphasizes that the healthcare system needs to embrace collaboration to find consensus in the way we measure and pay for health care value. Read the full article here.

2018-01-22T22:29:16+00:00 January 22nd, 2018|Viewpoints|

Open-Source Rx Value Model Designed To Encourage ‘More Productive’ Discussions

Pink Sheet Senior Writer, Cathy Kelly, reports on the goals and objectives of the IVI Open-Source Value Project (OSVP), how the first iteration of the tool on rheumatoid arthritis is intended to serve different health care stakeholders, and what the next application will focus on. Kelly quotes IVI Strategic Advisory Panel Chair, Sam Nussbaum, who [...]

2018-03-01T00:11:57+00:00 January 22nd, 2018|Press|